Precision Over Presumption: How Refined Diagnostics Are Restoring Azithromycin's Place in Targeted Infection Care
For years, azithromycin carried the weight of overuse criticism, but emerging clinical evidence and sharper diagnostic tools are prompting physicians to take a second look. Rather than abandoning the antibiotic entirely, a growing number of specialists are advocating for its strategic deployment in well-defined patient populations. Understanding which infections genuinely respond to azithromycin—and why—empowers patients to have more informed conversations with their providers.